Fig. 1From: Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinomaA Hepatoid carcinoma area. B Adenocarcinoma with enteroblastic differentiation. C Moderately poorly differentiated adenocarcinomas with positive AFP (D), GPC3 (E) and SALL4 (F). All X200Back to article page